It will be intriguing to determine whether targeting of TNFα to the tumor, or otherwise stimulating TNFR signaling at this site, may encourage differentiation of tumor vessels toward an HEV-like phenotype, and whether this will in turn enhance T cell infiltration further, and/or antitumor responses. The gene discussed is TNF; the disease is neoplasm.